AI assistant
NEOGENOMICS INC — Director's Dealing 2015
May 6, 2015
32227_dirs_2015-05-06_18ed0d98-5532-471f-98ba-cc8f704cf551.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2015-05-04
Reporting Person: HOREL ROBERT H. (Vice President GM PathLogic)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-04 | Stock Option (Right to Buy) | $4.78 | A | 50000 | Acquired | 2020-05-04 | Common Stock (0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.45 | 2016-05-20 | Common Stock (0) | 26218 | Direct |
| Stock Option (Right to Buy) | $1.69 | 2017-04-12 | Common Stock (0) | 25000 | Direct |
Footnotes
F1: On May 20, 2011 Mr. Horel was granted 50,000 stock options. These options vested ratably over the first four anniversaries of the grant date. On December 19, 2014 Mr. Horel exercised 23,782 options leaving a balance of 26,218
F2: On April 12, 2012 Mr. Horel was granted 25,000 stock options. 6,250 options vested immediately and 6,250 options vest on each of the next thre anniversaries from the grant date.
F3: On May 4, 2015 Mr. Horel was granted 50,000 stock options. These options vest ratably over the next 3 years on the anniversary date from date of grant.